HP

HealthInvest Partners Portfolio holdings

AUM $234M
1-Year Return 10.88%
This Quarter Return
-5.85%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$43.4M
AUM Growth
-$19.4M
Cap. Flow
-$19.7M
Cap. Flow %
-45.38%
Top 10 Hldgs %
88.87%
Holding
14
New
2
Increased
4
Reduced
6
Closed
2

Top Buys

1
VTRS icon
Viatris
VTRS
+$3.25M
2
UTMD icon
Utah Medical Products
UTMD
+$2.58M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$2.31M
4
OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
+$2.3M
5
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.85M

Top Sells

1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$8.93M
2
MCK icon
McKesson
MCK
+$6.52M
3
CAH icon
Cardinal Health
CAH
+$5.67M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.93M
5
CI icon
Cigna
CI
+$2.64M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
UTMD icon
1
Utah Medical Products
UTMD
$200M
$7.39M 17.03%
86,000
+30,000
+54% +$2.58M
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$4.04M 9.3%
1,265,000
+558,000
+79% +$1.78M
HRMY icon
3
Harmony Biosciences
HRMY
$1.86B
$3.71M 8.55%
76,000
-44,000
-37% -$2.15M
CI icon
4
Cigna
CI
$80.8B
$3.69M 8.5%
14,000
-10,000
-42% -$2.64M
GILD icon
5
Gilead Sciences
GILD
$142B
$3.59M 8.26%
58,000
-40,000
-41% -$2.47M
BMY icon
6
Bristol-Myers Squibb
BMY
$94B
$3.39M 7.81%
44,000
-38,000
-46% -$2.93M
BIIB icon
7
Biogen
BIIB
$21.2B
$3.26M 7.52%
16,000
-12,000
-43% -$2.45M
MCK icon
8
McKesson
MCK
$88.5B
$3.26M 7.52%
10,000
-20,000
-67% -$6.52M
VTRS icon
9
Viatris
VTRS
$11.6B
$3.25M 7.48%
+310,000
New +$3.25M
ZVRA icon
10
Zevra Therapeutics
ZVRA
$435M
$2.99M 6.89%
670,000
+415,000
+163% +$1.85M
OPNT
11
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$2.52M 5.8%
210,000
+192,000
+1,067% +$2.3M
AUPH icon
12
Aurinia Pharmaceuticals
AUPH
$1.68B
$2.31M 5.33%
+230,000
New +$2.31M
CAH icon
13
Cardinal Health
CAH
$36.4B
– –
-100,000
Closed -$5.67M
IRWD icon
14
Ironwood Pharmaceuticals
IRWD
$213M
– –
-710,000
Closed -$8.93M